{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Vehicle&page=3", "query": { "intervention": "Matching Vehicle", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 104, "total_pages": 11, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Vehicle&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Matching+Vehicle&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-29T01:24:05.977Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07013201", "title": "A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Palmoplantar Pustulosis" ], "interventions": [ { "name": "Delgocitinib cream", "type": "DRUG" }, { "name": "Vehicle cream", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LEO Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 135, "start_date": "2025-09-11", "completion_date": "2026-12-14", "has_results": false, "last_update_posted_date": "2026-10-01", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 7, "location_summary": "Fountain Valley, California • Douglasville, Georgia • West Bloomfield, Michigan + 4 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Douglasville", "state": "Georgia" }, { "city": "West Bloomfield", "state": "Michigan" }, { "city": "Elmhurst", "state": "New York" }, { "city": "Mayfield Heights", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07013201" }, { "nct_id": "NCT04030962", "title": "A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Dry Eye Disease", "Dry Eye Syndrome" ], "interventions": [ { "name": "AGN-242428", "type": "DRUG" }, { "name": "AGN-231868", "type": "DRUG" }, { "name": "AGN-242428 Vehicle", "type": "OTHER" }, { "name": "AGN-231868 Vehicle", "type": "OTHER" }, { "name": "Lifitegrast 5% Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 292, "start_date": "2020-03-04", "completion_date": "2022-03-18", "has_results": true, "last_update_posted_date": "2025-05-20", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Newport Beach, California • Colorado Springs, Colorado + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Andover", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04030962" }, { "nct_id": "NCT02597634", "title": "Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Delayed Onset Muscle Soreness, DOMS" ], "interventions": [ { "name": "SST-0225", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Strategic Science & Technologies, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "16 Years to 65 Years" }, "enrollment_count": 156, "start_date": "2015-11", "completion_date": "2016-10", "has_results": false, "last_update_posted_date": "2016-10-13", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 3, "location_summary": "Hollywood, Florida • South Miami, Florida • Springfield, Missouri", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02597634" }, { "nct_id": "NCT07016750", "title": "A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dystrophic Epidermolysis Bullosa", "DEB - Dystrophic Epidermolysis Bullosa", "Recessive Dystrophic Epidermolysis Bullosa", "Dominant Dystrophic Epidermolysis Bullosa" ], "interventions": [ { "name": "KB803", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Krystal Biotech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "ALL", "summary": "6 Months and older" }, "enrollment_count": 16, "start_date": "2025-06-20", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-03-12", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 5, "location_summary": "Rancho Santa Margarita, California • Coral Gables, Florida • Worcester, Massachusetts + 2 more", "locations": [ { "city": "Rancho Santa Margarita", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Worcester", "state": "Massachusetts" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07016750" }, { "nct_id": "NCT04284514", "title": "Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ocular Hypertension", "Primary Open Angle Glaucoma" ], "interventions": [ { "name": "AKB-9778 Ophthalmic Solution", "type": "DRUG" }, { "name": "Placebo Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aerpio Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 91, "start_date": "2019-05-02", "completion_date": "2019-12-15", "has_results": false, "last_update_posted_date": "2020-02-25", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 2, "location_summary": "Austin, Texas • Dallas, Texas", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04284514" }, { "nct_id": "NCT02022215", "title": "Efficacy and Safety Study of ME1111 in Patients With Onychomycosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Onychomycosis" ], "interventions": [ { "name": "ME1111 Solution, Low strength", "type": "DRUG" }, { "name": "ME1111 Solution, High strength", "type": "DRUG" }, { "name": "Matching Vehicle Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Meiji Seika Pharma Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 304, "start_date": "2013-12-19", "completion_date": "2016-03-01", "has_results": false, "last_update_posted_date": "2024-03-18", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 31, "location_summary": "Birmingham, Alabama • Encinitas, California • San Diego, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Encinitas", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02022215" }, { "nct_id": "NCT04089735", "title": "A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ocular Inflammation and Pain After Cataract Surgery" ], "interventions": [ { "name": "APP13007, 0.05%", "type": "DRUG" }, { "name": "APP13007, 0.1%", "type": "DRUG" }, { "name": "APP13007 Placebo, 0.05%", "type": "DRUG" }, { "name": "APP13007 Placebo, 0.1%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Formosa Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 165, "start_date": "2019-08-13", "completion_date": "2020-04-07", "has_results": true, "last_update_posted_date": "2023-06-27", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 9, "location_summary": "Phoenix, Arizona • Inglewood, California • Rancho Cordova, California + 5 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Inglewood", "state": "California" }, { "city": "Rancho Cordova", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04089735" }, { "nct_id": "NCT02844777", "title": "Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Actinic Keratosis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "5% VDA-1102", "type": "DRUG" }, { "name": "10% VDA-1102", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vidac Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 93, "start_date": "2016-07-15", "completion_date": "2017-05-26", "has_results": true, "last_update_posted_date": "2023-01-12", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02844777" }, { "nct_id": "NCT02688270", "title": "Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Raynaud's Phenomenon Secondary to Connective Tissue Disease" ], "interventions": [ { "name": "Vascana (0.9% nitroglycerin cream)", "type": "DRUG" }, { "name": "Vehicle Cream (placebo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Covis Pharma S.à.r.l.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 65, "start_date": "2016-06", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2022-11-02", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 1, "location_summary": "Multiple Locations, Pennsylvania", "locations": [ { "city": "Multiple Locations", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02688270" }, { "nct_id": "NCT02050334", "title": "CC100: Safety and Tolerability of Single Doses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "CC100", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chemigen, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 18, "start_date": "2013-11", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2015-04-30", "last_synced_at": "2026-10-29T01:24:05.977Z", "location_count": 1, "location_summary": "Indianapolis, Indiana", "locations": [ { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02050334" } ] }